Taken together, these observations suggest that GDYO binds ITGB2 and MRC2 directly, and this interaction facilitates attachment and entrance of GDYO into DNMT3A-mutant AML cells. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.